Loading organizations...
Positive Development is dedicated to providing family-centered, play-based autism care, focusing on children's intellectual and emotional development to foster lifelong success.
Positive Development has raised $97.0M across 2 funding rounds.
Positive Development has raised $97.0M in total across 2 funding rounds.
Positive Development has raised $97.0M across 2 funding rounds. Most recently, it raised $45.0M Debt in January 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 15, 2026 | $45M Debt Financing | Pinegrove Venture Partners, Megan Scheffel | — | Announced |
| Aug 1, 2025 | $52M Series C | B Capital Group, Flare Capital Partners | Amoon Fund, Digitalis Ventures, Healthworx | Announced |
Positive Development has raised $97.0M in total across 2 funding rounds.
Positive Development's investors include Pinegrove Venture Partners, Megan Scheffel, B Capital Group, Flare Capital Partners, aMoon Fund, Digitalis Ventures, Healthworx.
Positive Development is a Series C-stage healthcare technology company founded in 2019 that provides family-centered, play-based developmental therapy for children with autism and neurodivergent needs.[1][2][5] It offers integrated services including speech therapy, occupational therapy, mental health therapy, and Developmental Relationship-Based Interventions (DRBI), positioning itself as an alternative to traditional Applied Behavior Analysis (ABA) therapy by emphasizing individualized, home-based care that fosters emotional regulation, communication, social engagement, and daily living skills.[1][2][5] Serving about 1,200 clients across 23 service areas in eight states with 850 employees, the company has raised over $123M in funding, including a $51.5M Series C in August 2025 led by aMoon Fund, B Capital, and Flare Capital Partners, fueling expansion via payer partnerships, new markets, and its internal tech platform Stanley.[2][3]
The company targets families of neurodivergent children, delivering care at home with fewer hours (versus ABA's 30+ weekly) to build parent-child connections through play, promising cost savings, better outcomes, and scalability as the largest DRBI provider.[2][4][5] Recent growth includes leadership hires like a Chief Clinical Officer and CFO in July 2024, new centers in New Jersey, and ambitions to triple its client base.[1][2]
Positive Development was founded in 2019 in Monrovia, California (now headquartered in McLean, Virginia), initially under the name Principled Ventures.[1][3] While specific founder details are not publicly detailed in available sources, CEO Mike Suiters has led its evolution into a scaled autism care provider, emphasizing a developmental model that respects each child's neurotype, strengths, and processing style over compliance-based approaches.[2][5]
The idea emerged amid gaps in traditional ABA therapy, which often requires intensive sessions away from home; Positive Development pivoted to DRBI, integrating play-based therapies at home for relational growth.[2][5] Early traction built through de novo tech tools and payer-focused narratives on outcomes and costs, culminating in $72M raised by mid-2025 (pre-$51.5M round) and rapid expansion to eight states by August 2025.[1][2]
Positive Development rides the surging demand for neurodiversity-affirming autism care amid rising diagnoses (1 in 36 U.S. children) and criticism of ABA's intensity and efficacy.[2] Its timing aligns with payer shifts toward value-based models favoring outcomes over volume, enabling Medicaid/commercial partnerships and cost-conscious scaling in a $3B+ U.S. autism therapy market.[2]
Market forces like telehealth adoption post-COVID, tech integration in healthcare, and VC interest in "high-impact" healthtech propel its growth, positioning it as a disruptor to fragmented ABA providers.[2][4] By influencing ecosystems through scaled DRBI, payer innovations, and family empowerment, it advocates for accommodations over "fixing" neurotypes, potentially reshaping standards toward relational, tech-supported care.[5]
Positive Development is primed to dominate developmental autism therapy, leveraging its $51.5M raise to triple clients via market deepening, payer models, and Stanley platform enhancements.[2] Trends like AI-driven personalization in healthtech, neurodiversity movements, and capitated payments will accelerate its edge, though scaling clinician quality and regulatory hurdles in Medicaid loom as risks.
As the alternative to ABA gains traction, expect Positive Development to influence policy and ecosystems, empowering more families—echoing its mission to turn play into lifelong high achievement from day one.[5]
